Literature DB >> 27099315

A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.

Ekaterina A Korotkova1, Anatoly P Gmyl2, Maria L Yakovenko1, Olga E Ivanova2, Tatyana P Eremeeva2, Liubov I Kozlovskaya2, Armen K Shakaryan2, Galina Y Lipskaya3, Irina L Parshina4, Nataliya V Loginovskikh5, Nadezhda S Morozova6, Vadim I Agol7.   

Abstract

UNLABELLED: Four cases of acute flaccid paralysis caused by slightly evolved (Sabin-like) vaccine polioviruses of serotype 2 were registered in July to August 2010 in an orphanage of Biysk (Altai Region, Russia). The Biysk cluster of vaccine-associated paralytic poliomyelitis (VAPP) had several uncommon, if not unique, features. (i) Until this outbreak, Sabin-like viruses (in distinction to more markedly evolved vaccine-derived polioviruses [VDPVs]) were reported to cause only sporadic cases of VAPP. Consequently, VAPP cases were not considered to require outbreak-type responses. However, the Biysk outbreak completely blurred the borderline between Sabin-like viruses and VDPVs in epidemiological terms. (ii) The outbreak demonstrated a very high disease/infection ratio, apparently exceeding even that reported for wild polioviruses. The viral genome structures did not provide any substantial hints as to the underlying reason(s) for such pathogenicity. (iii) The replacement of intestinal poliovirus lineages by other Sabin-like lineages during short intervals after the disease onsets was observed in two patients. Again, the sequences of the respective genomes provided no clues to explain these events. (iv) The polioviruses isolated from the patients and their contacts demonstrated a striking heterogeneity as well as rapid and uneven evolution of the whole genomes and their parts, apparently due to extensive interpersonal contacts in a relatively small closed community, multiple bottlenecking, and recombination. Altogether, the results demonstrate several new aspects of pathogenicity, epidemiology, and evolution of vaccine-related polioviruses and underscore several serious gaps in understanding these problems. IMPORTANCE: The oral poliovirus vaccine largely contributed to the nearly complete disappearance of poliovirus-caused poliomyelitis. Being generally safe, it can, in some cases, result in a paralytic disease. Two types of such outcomes are distinguished: those caused by slightly diverged (Sabin-like) viruses on the one hand and those caused by significantly diverged VDPVs on the other. This classification is based on the number of mutations in the viral genome region encoding a viral structural protein. Until now, only sporadic poliomyelitis cases due to Sabin-like polioviruses had been described, and in distinction from the VDPV-triggered outbreaks, they did not require broad-scale epidemiological responses. Here, an unusual outbreak of poliomyelitis caused by a Sabin-like virus is reported, which had an exceptionally high disease/infection ratio. This outbreak blurred the borderline between Sabin-like polioviruses and VDPVs both in pathogenicity and in the kind of responses required, as well as underscoring important gaps in understanding the pathogenicity, epidemiology, and evolution of vaccine-derived polioviruses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27099315      PMCID: PMC4907227          DOI: 10.1128/JVI.00277-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range.

Authors:  Jaume Jorba; Ray Campagnoli; Lina De; Olen Kew
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

2.  Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.

Authors:  Dongmei Yan; Yong Zhang; Shuangli Zhu; Na Chen; Xiaolei Li; Dongyan Wang; Xiaozhen Ma; Hui Zhu; Wenbin Tong; Wenbo Xu
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

3.  Cis-element, oriR, involved in the initiation of (-) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary ('kissing') interactions.

Authors:  E V Pilipenko; K V Poperechny; S V Maslova; W J Melchers; H J Slot; V I Agol
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

4.  Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.

Authors:  Maria L Yakovenko; Elena A Cherkasova; Gennady V Rezapkin; Olga E Ivanova; Alexander P Ivanov; Tatyana P Eremeeva; Olga Y Baykova; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.

Authors:  Soile Blomqvist; Anne-Lise Bruu; Mirja Stenvik; Tapani Hovi
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

6.  Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.

Authors:  P M Strebel; N Ion-Nedelcu; A L Baughman; R W Sutter; S L Cochi
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

7.  Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.

Authors:  Yong Zhang; Shuangli Zhu; Dongmei Yan; Guiyan Liu; Ruyin Bai; Dongyan Wang; Li Chen; Hui Zhu; Hongqiu An; Olen Kew; Wenbo Xu
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

8.  Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.

Authors:  Mala Rakoto-Andrianarivelo; Sophie Guillot; Jane Iber; Jean Balanant; Bruno Blondel; Franck Riquet; Javier Martin; Olen Kew; Bakolalao Randriamanalina; Lalatiana Razafinimpiasa; Dominique Rousset; Francis Delpeyroux
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

9.  Reemergence of recombinant vaccine-derived polioviruses in healthy children, Madagascar.

Authors:  Richter Razafindratsimandresy; Marie-Line Joffret; Sendraharimanana Rabemanantsoa; Seta Andriamamonjy; Jean-Michel Heraud; Francis Delpeyroux
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

10.  Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011.

Authors:  Salmaan Sharif; Bilal Haider Abbasi; Adnan Khurshid; Muhammad Masroor Alam; Shahzad Shaukat; Mehar Angez; Muhammad Suleman Rana; Syed Sohail Zahoor Zaidi
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more
  5 in total

1.  Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.

Authors:  Guihua Tang; Wen Yin; Youde Cao; Liming Tan; Shuyu Wu; Yudong Cao; Xianyong Fu; Jing Yan; Xingjun Jiang
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

Review 2.  Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Authors:  P L Lopalco
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

3.  Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.

Authors:  Michael Famulare; Christian Selinger; Kevin A McCarthy; Philip A Eckhoff; Guillaume Chabot-Couture
Journal:  PLoS Biol       Date:  2018-04-27       Impact factor: 8.029

4.  Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.

Authors:  Ekaterina A Korotkova; Maria A Prostova; Anatoly P Gmyl; Liubov I Kozlovskaya; Tatiana P Eremeeva; Olga Y Baikova; Alexandr Y Krasota; Nadezhda S Morozova; Olga E Ivanova
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

Review 5.  The role of genetic sequencing and analysis in the polio eradication programme.

Authors:  David Jorgensen; Margarita Pons-Salort; Alexander G Shaw; Nicholas C Grassly
Journal:  Virus Evol       Date:  2020-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.